Insys Therapeutics (INSY) Tops Q3 EPS by 27c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Insys Therapeutics (INSY) Tops Q3 EPS by 27c

Insys Therapeutics Reports Record Third Quarter 2015 Results

November 5, 2015 6:50 AM EST

Announces Senior Management Changes and Appointments

Announces Stock Repurchase up to $50 Million

PHOENIX, Nov. 05, 2015 (GLOBE NEWSWIRE) -- Insys Therapeutics, Inc. (NASDAQ: INSY) ("Insys" or "the Company") today announced financial results for the three- and nine-month periods ended September 30, 2015. Highlights of and subsequent to the third quarter of 2015 include:

Quarter Highlights:

Total net revenue increased to $91.3 million compared to $58.3 million for the third quarter of 2014;Revenue from Subsys® (fentanyl sublingual spray) was $91.1 million,... More